Previous Close
$1.01
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$35.1 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses....
Community
- 0 posts discussing
0
Watchers
0
Visitors